COVID-19 Records

Reading Room Production — page 352

of 496 pages

← p.351 p.353 → · this page in the original PDF · package

to be ne a few 1). Many thanks. ; work for Dr. Ranganathan? > Can you give me some background on what Ms. Avery is likely to be interested > in hearing about. Is there anything I should know about MCMI to be appropriately prepared? > On 11/17/10 5:55 PM, "Hatchett, Richard J." > < @nss.eop.gov> wrote: >> Cyndi, Rajesh -- >> Thanks for being flexible. Ms. Avery was very interested in joining the discussion. We'll meet in her office (EEOB 426) but why don't you come a few >> minutes early and meet me in 421? >> Best, Richard >> -----Original Message----- >> From: Burrus-Shaw, Cyndi (NIH/OD) [E] [mailto @nih.gov] Sent: Wednesday, November 17, 2010 5:50 PM >> To: Hatchett, Richard J. Cc: Ranganathan, Rajesh (NIH/OD) [C] >> Subject: RE: Discussion about Cures Acceleration Network and the President's Medical Countermeasures Initiative (MCMI) >> Yes - that is fine. Dr. Ranganathan will be there on 11/22 at 12:00 pm. >> Please confirm that the location is still the same (EEOB, 421). Many thanks. >> Best, Cyndi >> -----Original Message----- >> From: Hatchett, Richard J. [mailto @nss.eop.gov] Sent: Wednesday, November 17, 2010 5:46 PM >> To: Burrus-Shaw, Cyndi (NIH/OD) [E] Subject: RE: Discussion about Cures Acceleration Network and the President's >> Medical Countermeasures Initiative (MCMI) >> Cyndi, >> Ms. Avery (Deputy Homeland Security Adviser to the President) can do 12:00p on >> Monday, but not 11:00a. Would this work for Dr. Ranganathan? >> Thanks, Richard > > ------ End of Forwarded Message

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/reading_room/352

Records on this page

RecordDateTypePages
RE: Discussion about Cures Acceleration Network and the President's 2010-11-17 email 352
RE: Discussion about Cures Acceleration Network and the President's 2010-11-17 email 352
Re: Discussion about Cures Acceleration Network and the President's 2010-11-17 email 351–352